86.90.E - Other human health activities notelsewhere classified
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
72.20.Z - Research and experimental development on social sciences and humanities
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
86.21.Z - General medical practice activities
86.22.Z - Specialist medical practice activities
86.23.Z - Dental practice activities
86.90.A - Physiotherapeutical activities
96.04.Z - Physical well-being activities
2022 | 2023 | ||
---|---|---|---|
M PLN | M PLN | % | |
Profit (loss) on sale | 4,1 | 4,8 | 18,2 |
Gross profit (loss) | 4,1 | 4,8 | 18,8 |
EBITDA | 4,3 | 5,1 | 19,2 |
Short time liabilities | 0,8 | 0,7 | -6,2 |
Other operating costs | 0 | 0 | -∞ |
Equity capital | 3 | 2,4 | -18,2 |
Operating profit (EBIT) | 4,1 | 4,8 | 18,8 |
Assets | 3,8 | 3,2 | -15,6 |
Net profit (loss) | 3,5 | 3,7 | 5,1 |
Cash | 0,7 | 0,6 | -16,5 |
Net income from sale | 11,6 | 14 | 21,3 |
Liabilities and provisions for liabilities | 0,8 | 0,7 | -6,2 |
Working assets | 2,9 | 2,6 | -11,3 |
Other income costs | 0 | 0 | 2404 |
Depreciation | 0,2 | 0,3 | 25,8 |
% | % | p.p. | |
Profitability of capital | 118,7 | 152,4 | 33,7 |
Equity capital to total assets | 78,8 | 76,4 | -2,4 |
Gross profit margin | 35,2 | 34,5 | -0,7 |
EBITDA Margin | 37,3 | 36,6 | -0,7 |
Days | Days | Days | |
Short term commitment turnover cycle | 25 | 19 | -6 |
Current financial liquidity indicator | 3.605502128601074 | 3.408010244369507 | -0,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane